-
Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients: Results From a Real-World Study in the United States and Germany
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Modifying Cardiovascular Disease Risk Factors in Qatar Using the Productivity-Adjusted Life Years (PALY) Metric
Sep 9, 2025, 16:22 PM -
Unmet Need in IgA Nephropathy (IgAN): Disparity Between Clinical Guidelines and Real-World Practice in Ireland
Sep 9, 2025, 16:22 PM -
Pharmacist-Led Education Improves Inhaler Satisfaction Adherence and Asthma Control in Asthma Patients
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Implementing AI-Assisted Contouring on Radiotherapy Staff and Workflows
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK
Sep 9, 2025, 16:22 PM -
Perspectives of Patients and Caregivers on Relapsed/Refractory Acute Myeloid Leukemia Treatments: A Mixed-Methods Interview Study
Sep 9, 2025, 16:22 PM -
Objective Real-World Caregiver Costs and Lost Time for Absences and Family Medical Leaves in the United States for Employees Whose Spouses Have Dementia and/or Alzheimer’s Disease and Patient Direct Costs
Sep 9, 2025, 16:22 PM -
The Mental Health Burden of Rare Diseases Based on Insights From Patients and Caregivers Through Rarepulse® Social Listening
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Viable Reimbursement and Financing Models for mHealth Interventions in Sub-Saharan Africa: A Narrative Review
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation Framework for Implementing a Digital Survivorship Passport for Childhood Cancer Survivors
Sep 9, 2025, 16:22 PM -
Changes in Physical Activity of Pediatric Patients Treated With Damoctocog Alfa Pegol During the Alfa-PROTECT Clinical Trial
Sep 9, 2025, 16:22 PM -
High All-Cause Hospitalization Among Those With Recurrent ASCVD Event: Evidence From a Large-Scale Real-World Database
Sep 9, 2025, 16:22 PM -
Utilization and Patient Characteristics of Robotic-Assisted Colorectal Surgery in Germany: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Staying Competitive in a Crowded Vaccine Market: Is There Room for a Third or Fourth Entrant in the Same Disease Area?
Sep 9, 2025, 16:22 PM -
Bayesian Dynamic Borrowing to Enhance Evidence for New Therapies
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Impact of Weight on Quality of Life–Lite Clinical Trials (IWQOL-Lite-CT) Version in Adults Participating in a Pharmacological Clinical Trial for Obesity
Sep 9, 2025, 16:22 PM -
Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review
Sep 9, 2025, 16:22 PM
